Related Experiment Video
Updated: Aug 11, 2025

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases
Moritz Hunkeler1,2, Cyrus Y Jin1,2, Eric S Fischer1,2
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Abstract:
Tight regulation of apoptosis is essential for metazoan development and prevents diseases such as cancer and neurodegeneration. Caspase activation is central to apoptosis, and inhibitor of apoptosis proteins (IAPs) are the principal actors that restrain caspase activity and are therefore attractive therapeutic targets. IAPs, in turn, are regulated by mitochondria-derived proapoptotic factors such as SMAC and HTRA2. Through a series of cryo-electron microscopy structures of full-length human baculoviral IAP repeat-containing protein 6 (BIRC6) bound to SMAC, caspases, and HTRA2, we provide a molecular understanding for BIRC6-mediated caspase inhibition and its release by SMAC. The architecture of BIRC6, together with near-irreversible binding of SMAC, elucidates how the IAP inhibitor SMAC can effectively control a processive ubiquitin ligase to respond to apoptotic stimuli.
Insights
Inhibitor of apoptosis proteins (IAPs) regulate cell death. This study reveals the structure of BIRC6, explaining how SMAC binding inhibits caspases, offering insights into apoptosis regulation and cancer therapies.
Area of Science:
- Molecular Biology
- Structural Biology
- Cell Death Research
Background:
- Apoptosis regulation is crucial for development and disease prevention.
- Inhibitor of Apoptosis Proteins (IAPs) control caspases, making them therapeutic targets.
- Mitochondrial proteins like SMAC and HTRA2 regulate IAPs.
Purpose of the Study:
- To elucidate the molecular mechanism of BIRC6-mediated caspase inhibition.
- To understand how SMAC binding releases caspase inhibition by BIRC6.
- To provide structural insights into IAP regulation by proapoptotic factors.
Main Methods:
- Cryo-electron microscopy (cryo-EM) of full-length human BIRC6.
- Structural analysis of BIRC6 in complex with SMAC, caspases, and HTRA2.
Main Results:
- Determined the architecture of BIRC6 bound to SMAC, caspases, and HTRA2.
- Revealed the mechanism of BIRC6-mediated caspase inhibition.
- Demonstrated near-irreversible binding of SMAC to BIRC6, explaining its inhibitory control.
Conclusions:
- The study provides a molecular understanding of BIRC6 function in apoptosis.
- SMAC's interaction with BIRC6 highlights a key regulatory mechanism in cell death pathways.
- Findings offer potential avenues for developing therapeutics targeting IAPs in diseases like cancer.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Apoptosis
Intralumenal Vesicles and Multivesicular Bodies

